Replay available

Baxter International Inc. (BAX) Q2 2026 Earnings Call

Baxter International Inc. (NYSE: BAX) Q2 2026 earnings conference call, held 2026-07-30. Replay captured from the company's public earnings webcast.

Thu, July 30, 2026 at 8:30 AMendedReplay
Baxter International Inc. (BAX) Q2 2026 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Kevin Moran

Vice President, Investor Relations at Baxter International

Andrew Heider

President and Chief Executive Officer

Anita Zelensky

Interim Chief Financial Officer, Chief Accounting Officer and Controller

Robert Marcus

at JPMorgan

Replay transcript excerpt

Morning, ladies and gentlemen, and welcome to Baxter International's Second Quarter twenty twenty six Earnings Conference Call. Your lines will remain in a listen only mode until the question and answer segment of today's call. You will need to press the star one key on your touch tone phone. As a reminder, this call is being recorded by Baxter and is copyrighted material. It cannot be recorded or rebroadcast without Baxter's permission. If you have any objections, please disconnect at this time. I would now like to turn the call over to Mr. Kevin Moran, Vice President, Investor Relations at Baxter International. Mr. Moran, you may begin. Good morning and welcome. Today, we'll discuss Baxter's second quarter results along with our updated financial outlook for the full year 2026. This morning, a press release was issued with our preliminary earnings results and updated outlook. The press release and investor presentation are available on the Investors section of the Baxter website. Joining me today are Andrew Heider, President and Chief Executive Officer and Anita Zelensky, Interim Chief Financial Officer, Chief Accounting Officer and Controller. During the call, we will be making forward looking statements, including comments regarding our updated financial outlook for the full year 2026 and the anticipated drivers of the third quarter and second half twenty twenty six performance the anticipated impact of various regulatory and operational matters, including ones related to our infusion pump platform and ongoing supply chain challenges and commentary regarding the global macroeconomic environment, including tariff impacts and the broader inflationary pressures. Forward looking statements involve risks and uncertainties, which could cause our actual results to diffe...

More from Baxter International Inc.